SCHEMBL160155

SCHEMBL160155

O=C(O)c1nc2ccccc2[nH]1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.61
JAK2 O60674 1/20 0.61
ABL1 P00519 1/20 0.61
NTRK1 P04629 1/20 0.61
LCK P06239 1/20 0.61
FYN P06241 1/20 0.61
CSF1R P07333 1/20 0.61
RET P07949 1/20 0.61
IGF1R P08069 1/20 0.61
MET P08581 1/20 0.61
PDGFRB P09619 1/20 0.61
PIM1 P11309 1/20 0.61
FGFR1 P11362 1/20 0.61
PRKACA P17612 1/20 0.61
KDR P35968 1/20 0.61
MAP2K2 P36507 1/20 0.61
CDK8 P49336 1/20 0.61
GSK3A P49840 1/20 0.61
GSK3B P49841 1/20 0.61
CDK7 P50613 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29414293 1.00 AURKA (0.61) AURKAJAK2ABL1NTRK1LCK
Hydrochloric Acid SCHEMBL3808279 0.98 AURKA (0.59) AURKAJAK2ABL1NTRK1LCK
Water SCHEMBL16239370 0.98 AURKA (0.59) AURKAJAK2ABL1NTRK1LCK
SCHEMBL28300126 0.98 AURKA (0.59) AURKAJAK2ABL1NTRK1LCK
SCHEMBL250171 0.86 CCND3 (0.70) AURKAJAK2ABL1NTRK1LCK
SCHEMBL1472885 0.85 AURKA (0.58) AURKAJAK2ABL1NTRK1LCK
Hydrochloric Acid SCHEMBL7000982 0.84 CCND3 (0.68) AURKAJAK2ABL1NTRK1LCK
SCHEMBL5358948 0.84 AURKA (0.61) AURKAJAK2ABL1NTRK1LCK
SCHEMBL9614275 0.83 NPC1 (0.52) PIN1RAB9AKDM4ESMN1; SMN2LMNA
SCHEMBL5319247 0.83 MAPT (0.49) AURKAJAK2ABL1NTRK1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1448 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12469929-B2 Separator, electrical apparatus containing such separator, and preparation method thereof CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2025-11-11 US claimed
CN-119875181-A Release film for electronic equipment and production method thereof 佛山市佳世达薄膜科技有限公司 2025-04-25 CN claimed
CN-119119024-A Carboxamide metal surface corrosion inhibitor material, effect verification method and application 北京理工大学 2024-12-13 CN claimed
CN-118994139-A Preparation method of formamide metal surface corrosion inhibitor 北京理工大学 2024-11-22 CN claimed
CN-118546475-A Irradiation crosslinking flame-retardant insulating material and preparation method thereof 安徽深联光电股份有限公司 2024-08-27 CN claimed
CN-117623711-A Quick-setting grouting material for reinforcing roadway surrounding rock 山西中晟圣达矿业安全工程技术有限公司 2024-03-01 CN claimed
CN-117551221-A Benzimidazolyl chitosan quaternary ammonium salt derivative and preparation and application thereof 中国科学院烟台海岸带研究所 2024-02-13 CN claimed
CN-117430737-A Catalyst component for olefin polymerization, catalyst and application thereof 中国石油化工股份有限公司 2024-01-23 CN claimed
CN-117430738-A Catalyst component for olefin polymerization, catalyst and application thereof 中国石油化工股份有限公司 2024-01-23 CN claimed
CN-116987211-B Benzimidazole acid-containing hydroxypropyl trimethyl chitosan quaternary ammonium salt derivative and preparation and application thereof 中国科学院烟台海岸带研究所 2023-12-01 CN claimed
EP-0920312-A4 APOPTOSIS INDUCING ADAMANTYL DERIVATIVES AND THEIR USAGE AS ANTI-CANCER AGENTS GALDERMA RES & DEV (FR) 2000-11-02 EP claimed
CN-1245431-A Medical composition and use thereof for manufacture of topical barrir formulation, UV-radiation absorbing formulation, or antiviral, antifungal, or antiinflammatory formulation NOVISCENS AB (SE) 2000-02-23 CN claimed
EP-0957927-A1 MEDICAL COMPOSITION AND USE THEREOF FOR THE MANUFACTURE OF A TOPICAL BARRIER FORMULATION, A UV-RADIATION ABSORBING FORMULATION, OR AN ANTIVIRAL, ANTIFUNGAL, OR ANTIINFLAMMATORY FORMULATION Noviscens AB (SE) 1999-11-24 EP claimed
EP-0920312-A1 APOPTOSIS INDUCING ADAMANTYL DERIVATIVES AND THEIR USAGE AS ANTI-CANCER AGENTS Galderma Research & Development (FR) 1999-06-09 EP claimed
WO-1998026788-A1 MEDICAL COMPOSITION AND USE THEREOF FOR THE MANUFACTURE OF A TOPICAL BARRIER FORMULATION, A UV-RADIATION ABSORBING FORMULATION, OR AN ANTIVIRAL, ANTIFUNGAL, OR ANTIINFLAMMATORY FORMULATION NOVISCENS AB (SE) 1998-06-25 WO claimed
WO-1998001132-A1 APOPTOSIS INDUCING ADAMANTYL DERIVATIVES AND THEIR USAGE AS ANTI-CANCER AGENTS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-01-15 WO claimed
US-5128065-A In aqueous environment BETZ LABORATORIES, INC. (US) 1992-07-07 US claimed
EP-0479572-A2 Inhibition of corrosion of copper or copper-bearing metals BETZ EUROPE, INC. (US) 1992-04-08 EP claimed
US-4814400-A Polybenzimidazole ester and carboxylic acid HOECHST CELANESE CORPORATION (US) 1989-03-21 US claimed
US-4662905-A REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) 1987-05-05 US claimed